StonvexLoading…
StonvexStonvexStonvexCore line items from JCI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Annual 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $11.94B | $5.80B | $23.60B | $17.15B |
Operating Income | $1.45B | $708.00M | $1.97B | $1.61B |
Net Income | $1.14B | $524.00M | $3.29B | $1.60B |
EPS (Diluted) | $1.86 | $0.85 | $5.03 | $2.42 |
Total Assets | $38.35B | $37.98B | $37.94B | $43.39B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $698.00M | $552.00M | $379.00M | $731.00M |
Free Cash Flow OCF − CapEx | $1.14B | $531.00M | $2.12B | $1.28B |
Shares Outstanding | 614.00M | 614.00M | 654.10M | 661.10M |